COPD

Optimism and Caution Lead the Way in Stem Cell Therapy Research for COPD

By

Tori Rodriguez, MA, LPC, AHC

David G. Hill and Jorge M. Mallea share their insight into stem cell therapy research for chronic obstructive pulmonary disease and provide an update on their pilot clinical trial.

Exploring the Use of Omics to Eliminate Sex and Gender Differences in COPD

By

Tori Rodriguez, MA, LPC, AHC

Although it has become widely accepted that COPD encompasses a range of phenotypes, the development of a precision medicine approach has been slow.

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

By

Amit Akirov, MD

Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.

High-Flow Nasal Therapy at Home Post Hospitalization for COPD Exacerbation

By

Naveed Saleh

An exploratory study assessed use of high flow nasal therapy to reduce moderate to severe COPD exacerbations in patients recently hospitalized for AECOPD.

Non-ICU Nasal High-Flow Therapy in COPD With Acute Hypoxic Respiratory Failure

By

Naveed Saleh

Investigators evaluated a hospital protocol change allowing administration of nasal high flow therapy outside the ICU in COPD with acute hypoxic respiratory failure.

Value of Active Strategy for Diagnosing Pulmonary Embolism in AECOPD

By

Brandon May

The SLICE trial assesses whether an active strategy for diagnosing pulmonary embolism improves outcomes in patients hospitalized for COPD exacerbations.

Effect of Air Pollution on Inflammation, Coagulation in Patients With AECOPD

By

Sheila Jacobs

To what extent do daily air pollution levels contribute to acute exacerbations of COPD?

The Role of Peripheral Eosinophil Counts in Identifying COPD Subtype

By

Brandon May

Researchers analyzed elevated FeNO levels and peripheral eosinophil counts to determine the prevalence of eosinophilic inflammation in patients with COPD.